Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Nemaura Med Inc (NMRD)

Nemaura Med Inc (NMRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Nemaura Med Inc 57 WEST 57TH STREET Manhattan NY 10019 USA

www.nemauramedical.com P: 646-416-8000

Description:

Nemaura Medical Inc. is a medical technology company. It engages in developing and commercializing non-invasive wearable diagnostic devices. The company is currently commercializing sugarBEAT(R), BEAT(TM) diabetes, and proBEAT(TM). SugarBEAT(R), a CE mark approved Class IIb medical device, is a non-invasive and flexible continuous glucose monitor. Nemaura Medical Inc. is based in New York, United States.

Key Statistics

Overview:

Market Capitalization, $K 2,905
Enterprise Value, $K -4,115
Shares Outstanding, K 40,352
Annual Sales, $ 80 K
Annual Net Income, $ -14,140 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -2,160 K
EBIT, $ -8,850 K
EBITDA, $ -7,430 K
60-Month Beta -0.06
% of Insider Shareholders 41.60%
% of Institutional Shareholders 4.41%
Float, K 23,566
% Float 58.40%
Short Volume Ratio 0.01

Growth:

1-Year Return -93.18%
3-Year Return -98.75%
5-Year Return -99.40%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth -5,600.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.12 on 02/12/24
Latest Earnings Date 02/23/24
Earnings Per Share ttm -0.50
EPS Growth vs. Prev Qtr -9.09%
EPS Growth vs. Prev Year -71.43%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 12/05/19

NMRD Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -142.69%
Profit Margin % -17,675.00%
Debt/Equity 0.00
Price/Sales 1,158.14
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.62
Interest Coverage -1.21
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar